new glp 1 drugs coming project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these at scale. Our Medicare GLP-1 Bridge: What to

3 Advantages of L-Ergothioneine Over Other Antioxidants The antioxidant activity of EGT has many advantages over other antioxidants such as GSH and ascorbic acid (Nielsen et al., 2015

References Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical Programme, 16 September 2025, Novo Nordisk, DAscanio AM, Mullally JA, Frishman WH

The main animal sources include lean meat, liver, heart, yeast, lamb, chicken, rabbit meat, milk and whey

Common side effects and management The GI side effect cluster, nausea, bloating, constipation, and diarrhea, affects the majority of semaglutide users to some degree

J Endocr Soc 2023